We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Two Lidocaine Administration Techniques

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01330134
First Posted: April 6, 2011
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Chicago
April 4, 2011
April 6, 2011
October 12, 2017
February 2011
April 2015   (Final data collection date for primary outcome measure)
Pain assessment: overall [ Time Frame: post procedure (day 1) ]
Visual analog scale (VAS), Revised Faces Pain Scale (RFPS), short form mcGill pain questionnaire (SF-MPQ)
Same as current
Complete list of historical versions of study NCT01330134 on ClinicalTrials.gov Archive Site
  • Pain Assessment: lidocaine injection [ Time Frame: post procedure (day 1) ]
    VAS, WBFS, SF-MPQ
  • Pain assessment: during procedure [ Time Frame: post procedure (day 1) ]
    VAS, WBFS, SF-MPQ
Same as current
Not Provided
Not Provided
 
Comparison of Two Lidocaine Administration Techniques
Comparison of Two Lidocaine Administration Techniques

The objective of our study is to determine if technique of lidocaine administration can decrease pain perception.

Hypothesis: There will be a significant difference in pain perception between patients who are given lidocaine on the skin surface prior to subcutaneous injection and patients who are given only subcutaneous injection by standard approach.

This is a single center prospective, randomized, blinded study assessing pain perception following 2 different lidocaine administration techniques in subjects who have planned medical procedures requiring local injection of lidocaine. Subjects will be approached and consented to participate in the study. They will be interviewed after the scheduled medical procedure to assess their pain using validated pain scores. An investigator who is not present for the procedure and blinded to the randomization will gather data regarding perceptions of pain from the entire procedure.
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Pain
  • Drug: lidocaine
    2ml 1% lidocaine placed onto surface of the skin immediately prior to 1% lidocaine subcutaneous injection
  • Drug: lidocaine
    1% lidocaine subcutaneous injection alone
  • Experimental: lidocaine onto skin prior to lidocaine subcutaneous injection
    Intervention: Drug: lidocaine
  • Active Comparator: lidocaine subcutaneous injection alone
    Intervention: Drug: lidocaine
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
490
April 2015
April 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Adult patients refered to the University of Chicago Medical Centers Procedure Service for a planned medical procedure requiring local injection of lidocaine.

Exclusion Criteria:

  • Patient who lack decisional capacity to consent
  • Patients who lack the ability to answer questions in english using pain scales
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01330134
10-621A
No
Not Provided
Not Provided
University of Chicago
University of Chicago
Not Provided
Principal Investigator: John P Kress, MD. Univeristy of Chicago
University of Chicago
June 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP